Technical VS fundementalAmgen Inc.BATS:AMGNMahdi_AsgariThe #UPC Court of Appeal confirmed the validity of Amgen's key Repatha patent (EP 797), securing its market lead against Sanofi. This massive legal victory clears the path for infringement proceedings and could potentially unlock value leading to a 50% stock increase! @Amgen: The Repatha shield is strong! @Sanofi: The battle continues. #Amgen #Repatha #Biotech #StockMarket #PatentLaw AMGN SNY